This study, referred to as INVESTED, is looking at whether one type of approved influenza vaccine will reduce cardiovascular and pulmonary problems more than another type of approved influenza vaccine in patients who have had a heart attack or heart failure.
Principal Investigator: Robert C. Long, MD, PharmD
Those eligible to participate in this study include:
Campus Maps / Parking
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005